Suzhou Fengbei Biotech Stock Co (SHSE:603334) Notes Receivable: ¥0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603334 Suzhou Fengbei Biotech Stock Co Ltd SHSE:603334
40 GF Score
Price ¥32.95
! 4 Warning Signs
View Full Analysis

What is Suzhou Fengbei Biotech Stock Co Notes Receivable?

Suzhou Fengbei Biotech Stock Co SHSE:603334 +3.65% 40 Notes Receivable is ¥0 Mil as of Mar. 2026. GuruFocus rates SHSE:603334 with a GF Score™ of 40/100. The stock has 4 warning signs investors should review.

Suzhou Fengbei Biotech Stock Co's Notes Receivable for the quarter that ended in Mar. 2026 was ¥0 Mil.

Suzhou Fengbei Biotech Stock Co Notes Receivable Related Terms

Suzhou Fengbei Biotech Stock Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for Suzhou Fengbei Biotech Stock Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Fengbei Biotech Stock Co Notes Receivable Chart

Suzhou Fengbei Biotech Stock Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Suzhou Fengbei Biotech Stock Co Quarterly Data
Dec20 Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:603334
40GF Score
Suzhou Fengbei Biotech Stock Co Ltd SHSE:603334
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Fengbei Biotech Stock Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ¥0 Mil mean?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Notes Receivable of ¥0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors.
Is Suzhou Fengbei Biotech Stock Co's Notes Receivable too high?
Suzhou Fengbei Biotech Stock Co's current Notes Receivable is ¥0 Mil. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Notes Receivable compare to WM and RSG?
Suzhou Fengbei Biotech Stock Co's Notes Receivable of ¥0 Mil can be compared against companies in the Waste Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Waste Management company?
A good Notes Receivable depends on the Waste Management industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. Suzhou Fengbei Biotech Stock Co's current Notes Receivable is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Notes Receivable of ¥0 Mil. The current Notes Receivable is ¥0 Mil. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Notes Receivable is ¥0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Suzhou Fengbei Biotech Stock Co Business Description

Address No. 1 Donghai Road, Yangtze River International Chemical Industrial Park, Jiangsu Province, Zhangjiagang, CHN, 215600
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
40GF Score

Get the complete analysis for SHSE:603334

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥32.95
Price